ATE306497T1 - Peptid für die diagnose und therapie von tumoren - Google Patents

Peptid für die diagnose und therapie von tumoren

Info

Publication number
ATE306497T1
ATE306497T1 AT03025866T AT03025866T ATE306497T1 AT E306497 T1 ATE306497 T1 AT E306497T1 AT 03025866 T AT03025866 T AT 03025866T AT 03025866 T AT03025866 T AT 03025866T AT E306497 T1 ATE306497 T1 AT E306497T1
Authority
AT
Austria
Prior art keywords
tumors
peptide
diagnosis
therapy
motif
Prior art date
Application number
AT03025866T
Other languages
English (en)
Inventor
Sabine Zitzmann
Sigrid Peschke
Miriam Mahmut
Walter Mier
Uwe Haberkorn
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE306497T1 publication Critical patent/ATE306497T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT03025866T 2003-11-11 2003-11-11 Peptid für die diagnose und therapie von tumoren ATE306497T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03025866A EP1531159B1 (de) 2003-11-11 2003-11-11 Peptid für die Diagnose und Therapie von Tumoren

Publications (1)

Publication Number Publication Date
ATE306497T1 true ATE306497T1 (de) 2005-10-15

Family

ID=34429327

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03025866T ATE306497T1 (de) 2003-11-11 2003-11-11 Peptid für die diagnose und therapie von tumoren

Country Status (4)

Country Link
EP (1) EP1531159B1 (de)
AT (1) ATE306497T1 (de)
DE (1) DE60301891T2 (de)
WO (1) WO2005044842A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1714978A1 (de) * 2005-04-19 2006-10-25 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Peptide zur Diagnose und Therapie von Tumoren
WO2012016713A1 (en) * 2010-08-05 2012-02-09 Ruprecht-Karls-Universität Heidelberg Tumour targeting with polypeptides
AU2012295366B2 (en) 2011-08-15 2017-05-25 Jyant Technologies Delivery system for specifically targeting cancer cells and method of use thereof
CN103204904B (zh) * 2013-02-01 2015-07-22 浙江海洋学院 一种抗前列腺癌赤魟软骨蛋白多肽及其制备方法和用途
CN105079817B (zh) * 2014-05-20 2018-05-18 中国人民解放军第二军医大学 靶向前列腺癌的药物递送载体、递送系统及其制备与应用

Also Published As

Publication number Publication date
EP1531159A1 (de) 2005-05-18
DE60301891T2 (de) 2006-07-27
WO2005044842A1 (en) 2005-05-19
EP1531159B1 (de) 2005-10-12
DE60301891D1 (de) 2006-02-23

Similar Documents

Publication Publication Date Title
BR0306715A (pt) Métodos para diagnóstico e tratamento de tumores
DE60222910D1 (de) Vaccinia virus für diagnose und behandlung von tumoren
DE50210317D1 (de) Peptid zur diagnose und therapie der alzheimer-demenz
ATE345387T1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
DE60039353D1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
DK2308975T3 (da) Antistofmolekyler, der har specificitet for human tumor nekrotiserende faktor alfa, og anvendelse deraf
ATE466084T1 (de) Hla-a24-restringiertes krebsantigenpeptid
DE60230046D1 (de) Peptide, die atherosklerotische schädigungen binden
DE60224419D1 (de) Von igf-bindungsprotein stammendes peptid
MX2007013626A (es) Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos.
IL203894A (en) Use of a polypeptide to prepare a drug to induce angiogenesis or liver regeneration
CY1116087T1 (el) Πεπτιδια λαμβανομενα απο ανθρωπινη bplp πρωτεϊνη, πολυνουκλεοτιδια που κωδικοποιουν τα εν λογω πεπτιδια και αντισωματα κατευθυνομενα εναντι των εν λογω πεπτιδιων
WO2005051315A3 (en) On-demand cleavable linkers for radioconjugates for cancer imaging and therapy
ATE435035T1 (de) Verbesserte linker für radiopharmazeutische verbindungen
ATE538811T1 (de) Zytotoxizitätsvermittlung von zellen mit hinweisen auf oberflächenexpression von cd44
DE60301891D1 (de) Peptid für die Diagnose und Therapie von Tumoren
WO2004076614A3 (de) Humane nukleinsäuresequenzen aus prostatakarzinomen
ATE514780T1 (de) Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon
DE60035192D1 (de) Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung
IL207012A (en) 28sgp medicinal product and 28sgp accent cancer treatment vaccine
ATE480552T1 (de) Stq-peptide
ATE328899T1 (de) Zellkernlokalisierendes protein für beta-catenin
ATE328082T1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
MXPA03005500A (es) Proteina humana novedosa que contiene una repeticion rica en leucina, expresada predominantemente en intestino delgado, hlrrsi1.
DE60108622D1 (de) Arzneimittel zur anwendung bei tumorkrankheiten welches ro5-4864 und ein apoptoseauslöser enthält

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties